It would also assist in further weight loss or reduction in other medications to reduce polypharmacy. Oral semaglutide is only currently approved for treating type 2 diabetes, with only two GLP-1-related injectables liraglutide and Wegovy approved for treating obesity
Some patients report eating significantly smaller portion sizes, and many experience food aversions or nausea, particularly during the initial titration phase
However, a randomized placebo-controlled trial evaluating liraglutide in glucose-tolerant obese psoriasis patients showed no significant changes in PASI or Dermatology Life Quality Index (DLQI) scores after 8 weeks of treatment compared with placebo treatment [209]
[DOI] [PMC free article] [PubMed] [Google Scholar] 146.Diz-Chaves Y, Mastoor Z, Spuch C, Gonzalez-Matias LC, Mallo F
NAION occurs when blood flow to the optic nerve becomes insufficient, resulting in sudden, typically permanent vision loss in one eye
Contact us today by phone or book an appointment online